Markets - Real-time Stock Market Data & Analysis

Jagsonpal Pharmaceuticals Ltd has demonstrated a significant shift in price momentum, with technical indicators signalling a transition from a mildly bullish to a bullish trend. The stock’s recent surge of 7.95% on 25 Sep 2026, coupled with robust weekly and monthly MACD and Bollinger Bands readings, highlights renewed investor confidence in this micro-cap pharmaceutical player.

Jagsonpal Pharmaceuticals Ltd

Read Full Analysis

News Feed

Latest market updates

11 hours ago

Quarterly Earnings Review: Mixed Results Mark Jun-2026 with Large Caps Leading Profit Growth

The June 2026 quarterly earnings season has concluded with 4,274 companies reporting results, revealing a cautious but improving corporate earnings landscape. While the proportion of companies delivering positive results has stabilised at 54.0%, large-cap firms continue to outperform their smaller counterparts, signalling a divergence in sectoral and market-cap performance trends.

14 hours ago

Quarterly Earnings Review: Mixed Results Mark Jun-2026 with Large Caps Leading Gains

The Jun-2026 quarterly earnings season has revealed a cautious but improving corporate performance landscape, with 54.0% of companies reporting positive results. Large-cap stocks have outperformed their mid- and small-cap counterparts, signalling a selective recovery amid ongoing economic uncertainties.

16 hours ago

Sensex and Nifty Slip Sharply as Market Breadth Weakens; IT Sector Offers Rare Relief

Indian equity markets closed sharply lower on 24 Sep 2026, with the Sensex falling 1,247.71 points (-1.67%) to 73,580.54 and the Nifty shedding 383.7 points (-1.64%) to settle at 23,063.10. Market breadth was notably weak, with only three sectors advancing against 35 in decline, reflecting broad-based selling pressure amid subdued investor sentiment.

16 hours ago

Mid-Cap Segment Sees Broad Weakness as BSE Midcap Index Declines 2.07%

The BSE Midcap 150 index experienced a notable decline of 2.07% on 24 Sep 2026, continuing a recent downtrend with a 1.44% drop over the past five trading sessions. Market breadth was weak, with advancing stocks heavily outnumbered by decliners, reflecting broad-based selling pressure across the mid-cap segment.

16 hours ago

Small-Cap Segment Faces Downward Pressure Amid Broad Market Weakness

The small-cap segment, represented by the BSE SMALLCAP 250 index, has experienced a notable decline, falling 1.28% on the day and registering a 0.78% drop over the past five trading sessions. Despite this recent weakness, select stocks within the segment have delivered strong returns, highlighting a mixed performance amid broader market pressures.

Load More Stories

Opportunities for You

Premium

Results Corner

IPO Corner

Live

Loading IPOs...